- Fund Type: Open-End Fund
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Global
Adamant Funds - Adamant Global Generika Fund
+ Add to WatchlistADAGGRI:SW
1,195.24 CHF 10.52 0.87%As of 11:24:00 ET on 05/16/2013.
Snapshot for Adamant Funds - Adamant Global Generika Fund (ADAGGRI)
| Year To Date: | +15.45% | 3-Month: | +8.48% | 3-Year: | - | 52-Week Range: | 927.49 - 1,205.76 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +4.93% | 1-Year: | +27.79% | 5-Year: | - | Beta vs SMI: | 0.79 |
Fund Profile & Information for ADAGGRI
Adamant Global Generika Fund is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the generic sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.
| Inception Date: | 07-16-2010 | Telephone: | +41 800 850 050 |
|---|---|---|---|
| Managers: | OLIVER KUBLI | ||
| Web Site: | www.zkb.ch/fonds | ||
Fundamentals for ADAGGRI
| NAV | (on 2013-05-16) 1,195.24 |
|---|---|
| Assets (M) | (on 2013-05-16) 154.55 |
| Fund Leveraged | N |
| Minimum Investment | 100,000.00 |
| Minimum Subsequent Investment | - |
Dividends for ADAGGRI
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Irreg |
| Last Dividend Net | (on 2012-12-05) 4.00 |
| Dividend Yield (ttm) | 0.33 |
Fees & Expenses for ADAGGRI
| Front Load | 1.20 |
|---|---|
| Back Load | 1.00 |
| Current Mgmt Fee | 1.20 |
| Redemption Fee | 1.00 |
| 12b1 Fee | - |
| Expense Ratio | 1.22 |
Top Fund Holdings for ADAGGRI
Filing Date: 01/31/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Hikma Pharmaceuticals PLC | 450,000 | 5,239,011 | 3.747% |
| Kalbe Farma Tbk PT | 47,500,000 | 4,839,927 | 3.462% |
| Richter Gedeon Nyrt | 30,000 | 4,707,185 | 3.367% |
| Celltrion Inc | 107,500 | 4,611,158 | 3.298% |
| Dr Reddy's Laboratories Ltd | 130,000 | 4,254,038 | 3.043% |
| Catamaran Corp | 89,818 | 4,236,949 | 3.030% |
| Tsumura & Co | 140,000 | 4,204,304 | 3.007% |
| Mylan Inc/PA | 150,000 | 3,860,975 | 2.761% |
| Sawai Pharmaceutical Co Ltd | 40,000 | 3,747,357 | 2.680% |
| Chong Kun Dang Pharm Corp | 104,780 | 3,719,121 | 2.660% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page